Collaborate Disseminate
Two newly published studies indicate a fourth COVID-19 vaccine dose can substantially boost a person’s immunity and reduce the risk of infection compared to triple-dosed individuals. Most fourth-dose programs around the world are currently limited to t… Continue reading Experts divided over who should get a 4th COVID vaccine dose
COVID-19 variant-tracking estimates from the Centers for Disease Control and Prevention (CDC) indicate a new Omicron sub-variant is rapidly becoming prevalent in the United States. Dubbed BA.2.12.1, little is known about this novel variant beyond it li… Continue reading More infectious Omicron subvariant BA.2.12.1 rapidly spreading across US
Among the many ways scientists hope to be able to tackle Alzheimer’s is by preventing it from taking hold in the first place, or at least averting its worst effects. This idea of a vaccine for Alzheimer’s is gaining traction as scientists continue to devise new ways of clearing the brain of toxic proteins hypothesized to be key drivers of the condition. A newly published study has hinted at further possibilities in this area, with a protein derived from corn used to induce an immune response and improve memory in mice with the disease.
Tags: University of Kansas, Alzheimer’s Disease, Vaccines
Continue reading Protein derived from corn boosts memory in mice with Alzheimer’s
New research published in Nature Medicine has found COVID-19 vaccination can reduce a person’s infectious viral load. The study compared the infectiousness of different SARS-CoV-2 variants between vaccinated and unvaccinated subjects.Continue ReadingCa… Continue reading mRNA vaccination found to reduce COVID-19 infectious viral load
Preliminary data presented at the American Association of Cancer Research Annual Meeting has provided promising signs for a new cancer treatment that combines immunotherapy with an mRNA vaccine. The first reports from the Phase 1 human trial indicate t… Continue reading mRNA vaccine boosts cancer immunotherapy in early human trial data
A new study published in the New England Journal of Medicine is offering some of the first real-world data on COVID-19 vaccine effectiveness against the Omicron variant in children aged 5 to 11. The findings reveal vaccination reduce a child’s risk of severe illness and hospitalization by two-thirds compared to unvaccinated children.
Category: Health & Wellbeing, Lifestyle
Tags: Coronavirus (COVID-19), Children, Boston Children’s Hospital, Vaccines, Virus
Continue reading COVID vaccines in children cut Omicron hospitalizations by 68%
The U.S. Food and Drug Administration (FDA) has authorized a fourth mRNA vaccine dose for all individuals aged 50 and over. The authorization includes both Pfizer and Moderna vaccines and is recommended to be administered at least four months after a t… Continue reading Fourth COVID-19 mRNA vaccine dose approved for all older Americans
A new case report published in the Journal of Clinical Immunology has presented the first description of a mRNA COVID-19 vaccine being used to therapeutically treat a patient experiencing a persistent SARS-CoV-2 infection. The immunocompromised patient… Continue reading First use of mRNA COVID vaccine to treat persistent SARS-CoV-2 infection
Biotech company Moderna has announced the first interim data from a clinical trial testing its mRNA COVID-19 vaccine in children under the age of six. The results show similar antibody responses after two doses to those seen in adults. Moderna plans to… Continue reading Moderna reports early success with COVID vaccine in children under 6
Research published in The New England Journal of Medicine offers the first insights into the efficacy of a fourth COVID-19 vaccine dose. The data from a health care worker trial in Israel found a fourth dose only offers “marginal benefits” over three d… Continue reading 4th COVID vaccine dose offers “marginal benefits” in healthy adults